Search for: "NOVARTIS PHARMACEUTICALS CORP. v. Abbott Laboratories"
Results 21 - 40
of 45
Sorted by Relevance
|
Sort by Date
22 Apr 2010, 3:51 am
Labs. et al (Orange Book Blog) (FDA Law Blog) Seroquel (Quetiapine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Astrazeneca et al v Anchen Pharmaceuticals et al (Patent Docs) Simcor (Niacin, Simvastatin) – US: District Court Delaware: Patent infringement complaint following Para IV challenge: Abbott Laboratories et al. v. [read post]
27 May 2010, 3:20 am
(Spicy IP) Trilipix (Fenofibrate) – US: Patent infringement complaint following Paragraph IV challenge: Abbott Laboratories et al. v. [read post]
5 Apr 2013, 1:01 pm
Abbott Laboratories, C.A. [read post]
2 Dec 2011, 2:00 pm
Novartis Pharmaceuticals Corp., ___ Fed. [read post]
24 Aug 2015, 5:00 am
Abbott Laboratories, Inc., ___ F. [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
13 May 2010, 12:27 pm
Novartis Pharmaceuticals Corp., 642 F. [read post]
29 Dec 2010, 2:57 am
Highlights this week included: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
22 Dec 2011, 11:59 am
Novartis Pharmaceuticals Corp., 793 F. [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
28 Dec 2012, 1:57 pm
McNeil Consumer & Specialty Pharmaceuticals, 672 F.3d 372 (5th Cir. 2012). [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
21 Dec 2012, 11:41 am
Mutual Pharmaceutical Co., 678 F.3d 30 (1st Cir. 2012). [read post]
30 Jun 2011, 5:00 am
Wyeth Laboratories, 510 F. [read post]
22 Jan 2009, 2:06 am
Alad Corp., 19 Cal.3d 22, 31 (1977). [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty)… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
28 Oct 2011, 7:00 am
Abbott Laboratories, Inc., 259 F.3d 1226, 1235 (10th Cir. 2001) ([the prescribing nurse’s] “failure to read the label - a basic task which she was trained to perform - was an efficient intervening cause of [plaintiff’s] injury”) (applying Kansas law). [read post]
